Mark Elliott Brecher, a pathologist and a former vice chair of the Department of Pathology and Laboratory Medicine at UNC-Chapel Hill, is the new chief medical officer at Laboratory Corporation of America (NYSE: LH).

“Dr. Brecher is a well-respected clinician, researcher, and leader in the field of pathology,” said David King, LabCorp’s chief executive officer. “His appointment underscores LabCorp’s commitment to clinical and scientific leadership.”

Brecher is the immediate past chair of the U.S. Department of Health and Human Services Advisory Committee on Blood Safety and Availability.